WaveClear, Inc. announces the closing of a $1,125,000 Series-A round of investment led by Hunniwell Lake Ventures. They will use their funds to further develop the CaviClearTM Endovascular System, a minimally invasive and cost-effective ultrasound generated cavitation device for a broad range of endovascular applications. Read More ⇒
Hunniwell's Series B Investment CoapTech was recently awarded $1.6 Million from NIH to finalize the development and trial of its Pediatric PUMA-G System.
Hunniwell Lake Ventures Analyst explains how the recent wave of innovations in miniature surgical robotics is expanding their applications while improving quality and safety.
CoapTech Co-Founders CEO Howard Carolan and CMO Steve Tropello share their journey founding CoapTech and developing the novel PUMA system in order to relieve patient suffering and improve quality.
HLV Founding Managing Partner Richard Fang shares his personal entrepreneurial experience, as well as the motivation and the differentiating strategies behind the Hunniwell Medical Device Fund.
Hunniwell Lake Ventures (HLV) is a Palo Alto-based VC firm that invests exclusively in medical devices. Its mission is to make surgery safer, more accessible and less invasive by investing in innovations that help surgeons visualize the operative field better, employ surgical tools using improved and advanced technologies to treat the patient, and ensure their speedy recovery through the best wound closure and tissue healing technologies available.